MAROTTA, CARLO
 Distribuzione geografica
Continente #
EU - Europa 75
AS - Asia 49
NA - Nord America 43
AF - Africa 7
SA - Sud America 3
Totale 177
Nazione #
IT - Italia 53
US - Stati Uniti d'America 43
CN - Cina 26
SG - Singapore 18
CI - Costa d'Avorio 5
FR - Francia 5
BE - Belgio 3
DE - Germania 3
IN - India 3
BR - Brasile 2
IE - Irlanda 2
NL - Olanda 2
SE - Svezia 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
IR - Iran 1
LT - Lituania 1
PL - Polonia 1
Totale 177
Città #
Santa Clara 25
Singapore 13
Livorno 12
Milan 10
Pisa 10
Shanghai 10
Abidjan 5
Boardman 5
Lucca 4
Brussels 3
Frankfurt am Main 3
Fuzhou 3
Kent 3
Quanzhou 3
Vicopisano 3
Amsterdam 2
Bhubaneswar 2
Dakar 2
Dublin 2
Empoli 2
Florence 2
Ogden 2
Pessac 2
Romainville 2
Rome 2
Wuhan 2
Beijing 1
Bern 1
Brno 1
Campiglia Marittima 1
Dubai 1
Hangzhou 1
Hyderabad 1
Jataizinho 1
London 1
Los Angeles 1
Manzano 1
Marseille 1
Massa 1
Massarosa 1
Natal 1
Navacchio 1
Santiago 1
Tehran 1
Warsaw 1
Zhengzhou 1
Zhenjiang 1
Totale 155
Nome #
An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies 73
Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments 43
Exploiting the Chemical Diversity of Metal Compounds as a Source of Novel Anti-COVID-19 Drugs 28
Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth - An Investigation of the Activation Mechanism and Their Nanoformulation 27
A Snapshot of the Most Recent Transthyretin Stabilizers 16
Reevaluating the Mechanistic Insights of α-TOS-Bearing Pt(IV) Anticancer Complexes: A New Perspective from a More In-Depth Knowledge 15
Totale 202
Categoria #
all - tutte 881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202342 0 0 0 0 0 0 12 6 19 2 0 3
2023/202454 10 6 8 1 1 0 1 1 1 4 14 7
2024/2025106 1 6 1 19 24 29 26 0 0 0 0 0
Totale 202